FIELD: medicine. SUBSTANCE: method involves 30 days treatment course using schedule prescriptions of parathyroid hormone at amount 4-15 IU/kg per day, at least once for 7 days for each of indicated 30 days of treatment. Bisphosphonate is administrated at amount about 0.0005-1.0 mg P/kg per day, at least for one day for each of indicated 30 days treatment course. EFFECT: enhanced effectiveness of treatment. 10 cl
| Title |
Year |
Author |
Number |
| USE OF BIS-PHOSPHONATES AND PARATHYROID GLAND EXTRACT FOR OSTEOPOROSIS TREATMENT |
1992 |
- Ehnn Danbar Dzheddes[Us]
- Roudzhli Vejt Bojs[Us]
|
RU2104699C1 |
| USE OF PHOSPHONATES AND NONSTEROID ANTIINFLAMMATORY DRUGS FOR TREATMENT OF PATIENTS WITH ARTHRITIS, METHOD OF TREATMENT |
1993 |
- Kristin Khovanchik
- Marion Dehvid Frehnsis
- Richard Allen Andervud
|
RU2119794C1 |
| METHOD OF OSTEOPOROSIS TREATMENT, COMPOSITION FOR OSTEOPOROSIS TREATMENT, USE OF PHOSPHONATE AND ESTROGENIC HORMONE ACTING ON BONE FOR OSTEOPOROSIS TREATMENT |
1992 |
|
RU2113848C1 |
| THIOSUBSTITUTED PYRIDINYLBISPHOSPHONIC ACIDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS OR ESTERS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT |
1993 |
- Sjuzn Mehri Kaas
- Frank Khehllok Ibitino
- Marion Dehvid Frehnsiz
|
RU2124019C1 |
| SULFUR-CONTAINING PHOSPHONIC ACIDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS OR ESTERS AND PHARMACEUTICAL COMPOSITION BASED ON SAID |
1993 |
- Sjuzn Mehri Kaas
- Frank Khehllok Ibitino
- Marion Dehvid Frehnsiz
|
RU2136691C1 |
| QUATERNARY NITROGEN CONTAINING PHOSPHONATES FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM AND FOR PROPHYLAXIS AND TREATMENT OF TOOTH DEPOSITS AND TOOTH CALCULUSES, PHARMACEUTICAL COMPOSITION, METHOD OF MEDICAL TREATMENT |
1993 |
- Frank Khehllok Ibitino
- Sjuzn Mehri Kaas
- Marion Dehvid Frehnsiz
- Dennis Dzhordzh Ehntoni Nilson
- Dzhon Majkl Dzhenuz
|
RU2126414C1 |
| CYCLIC UREA COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT |
1992 |
- Stehnford Sal'Vatore Pelozi
- Chia-Nien Ju
|
RU2142461C1 |
| COMPOUNDS OF CYCLIC URETHAN OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF HUMAN AND OTHER MAMMALIAN TREATMENT SUFFERING WITH CARDIAC ARRHYTHMIA AND/OR ATRIAL FIBRILLATION, A PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PATIENTS WITH ARRHYTHMIA AND FIBRILLATION |
1992 |
- Stehnford Sal'Vatore Pelozi
- Chia-Nien Ju
|
RU2125568C1 |
| UREA 4-OXOCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF PATIENT TREATMENT |
1992 |
- Stehnford Sal'Vatore Pelozi, Ml.
- Chia-Nien Ju
- Mark Artur Kalkagno
|
RU2130935C1 |
| METHOD FOR TREATMENT OF OSSEOUS DISORDERS |
2002 |
- Shofild Pamela Dzhean
- Van Den Berg Genri
- Burdzhio Dehvid Ehrnest
- Chajns Arkadi Aaron
|
RU2294203C2 |
